Mind Medicine (MindMed) Inc. (MNMD)
Last updated: 2026-10-20 09:26:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Mind Medicine (MindMed) Inc. (MNMD) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Mind Medicine (MindMed) Inc. (MNMD) Pre-Market Stock Price
Mind Medicine (MindMed) Inc. (MNMD) is trading at $-- in pre-market trading as of --, -- from the previous close of $--
Pre-market trading shows how investors are pricing MNMD before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.
Mind Medicine (MindMed) Inc. (MNMD) 7-Day Stock Price Change
Over the past seven days, Mind Medicine (MindMed) Inc. (MNMD) moved from $13.70 to $15.02, representing a gain of 9.64% ($1.32).
The stock traded between $12.88 and $15.29 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 2.47 million shares, up versus the previous seven-day period, indicating higher trading activity.
What is Mind Medicine (MindMed) Inc. (MNMD)?
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
Mind Medicine (MindMed) Inc. Information
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 74 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Mind Medicine (MindMed) Inc. (MNMD) Stock on MEXC
Eligible investors can buy real shares of Mind Medicine (MindMed) Inc. (MNMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Mind Medicine (MindMed) Inc. (MNMD) stock price today?
2.Is MNMD stock going up or down today?
3.What is MNMD pre-market price?
4.What is MNMD after-hours price?
5.Is MNMD stock trading now?
6.Where does MNMD sit relative to its 52-week high and low?
7.What sector is Mind Medicine (MindMed) Inc. in?
8.What is Mind Medicine (MindMed) Inc.'s market capitalization and where is it listed?
9.How is MNMD valued in terms of P/E ratio and EPS?
10.Does Mind Medicine (MindMed) Inc. pay a dividend?
Explore More US Stocks
Search Stocks
MNMD Stock Calculator
Estimate the value between MNMD shares and USD.
MNMD Shares to USD
1.00 MNMD shares = 0 USD
Calculations are estimates based on the latest available price and are for reference only.


